Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Jun 30, 2025 | (FY)Jun 30, 2024 | (FY)Jun 30, 2023 | (FY)Jun 30, 2022 | (FY)Jun 30, 2021 | (FY)Jun 30, 2020 | (FY)Jun 30, 2019 | (FY)Jun 30, 2018 | (FY)Jun 30, 2017 | (FY)Jun 30, 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -67.57%3.17K | -91.95%9.77K | 5.31%121.4K | -4.01%115.28K | -80.38%120.09K | |||||
| Operating revenue | ---- | ---- | ---- | ---- | ---- | -67.57%3.17K | -91.95%9.77K | 5.31%121.4K | -4.01%115.28K | -80.38%120.09K |
| Cost of revenue | -81.09%109.99K | |||||||||
| Gross profit | -67.57%3.17K | -91.95%9.77K | 5.31%121.4K | 1,040.92%115.28K | -66.74%10.1K | |||||
| Operating expense | -23.05%1.69M | 3.32%2.2M | -10.38%2.13M | 4.08%2.38M | -27.87%2.28M | -24.12%3.17M | -5.01%4.17M | -18.18%4.39M | 32.66%5.37M | 21.88%4.05M |
| Selling and administrative expenses | -48.70%672.99K | --1.31M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 5.87%1.63M |
| -General and administrative expense | -48.70%672.99K | --1.31M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 5.87%1.63M |
| Research and development costs | 183.84%641.67K | -82.74%226.07K | -10.49%1.31M | -9.08%1.46M | -32.49%1.61M | -28.39%2.38M | -4.95%3.33M | -21.15%3.5M | 87.86%4.44M | 33.26%2.36M |
| Depreciation amortization depletion | ---- | ---- | -25.03%557 | -84.45%743 | -71.65%4.78K | -67.78%16.85K | -15.74%52.3K | -17.37%62.07K | 51.75%75.12K | 1,198.56%49.5K |
| -Depreciation and amortization | ---- | ---- | -25.03%557 | -84.45%743 | -71.65%4.78K | -67.78%16.85K | -15.74%52.3K | -17.37%62.07K | 51.75%75.12K | 1,198.56%49.5K |
| Other operating expenses | -42.83%378.85K | -19.17%662.69K | -10.19%819.89K | 36.34%912.92K | -12.51%669.61K | -3.23%765.32K | -4.44%790.89K | -2.73%827.65K | --850.85K | ---- |
| Operating profit | 23.05%-1.69M | -3.32%-2.2M | 10.38%-2.13M | -4.08%-2.38M | 27.80%-2.28M | 24.01%-3.16M | 2.54%-4.16M | 18.69%-4.27M | -30.13%-5.25M | -22.69%-4.04M |
| Net non-operating interest income (expenses) | 10.26%138.05K | 197.98%125.2K | 1,133.95%42.02K | -55.20%3.41K | -86.33%7.6K | -54.88%55.61K | -17.54%123.25K | 5.15%149.48K | 15.42%142.16K | -37.23%123.17K |
| Non-operating interest income | 12.66%141.05K | 197.98%125.2K | 1,133.95%42.02K | -55.20%3.41K | -86.33%7.6K | -54.88%55.61K | -17.54%123.25K | 5.15%149.48K | 15.42%142.16K | -39.53%123.17K |
| Non-operating interest expense | --3K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Other net income (expenses) | 176.48%15.33K | 0.70%-20.04K | -3,360.10%-20.18K | -99.83%619 | -79.04%365.79K | 242.65%1.74M | -85.38%509.26K | 326.71%3.48M | 5.95%816.22K | 119.48%770.37K |
| Special income (charges) | ---- | ---2.11K | ---- | ---12.31K | ---- | ---148.2K | ---- | ---- | ---- | ---- |
| -Gain on sale of property,plant,equipment | ---- | ---2.11K | ---- | ---12.31K | ---- | ---148.2K | ---- | ---- | ---- | ---- |
| Other non-operating income (expenses) | 185.47%15.33K | 11.15%-17.93K | -256.12%-20.18K | -96.47%12.93K | -80.68%365.79K | 271.75%1.89M | -85.38%509.26K | 326.71%3.48M | -2.57%816.22K | 647.33%837.73K |
| Income before tax | 26.50%-1.54M | 0.57%-2.1M | 11.15%-2.11M | -24.49%-2.37M | -41.63%-1.91M | 61.31%-1.35M | -503.43%-3.48M | 86.34%-576.29K | -36.40%-4.22M | 56.08%-3.09M |
| Income tax | -737.18K | 0 | 0 | 6.77%-414.73K | -18.02%-444.86K | -27.27%-376.92K | -46.75%-296.15K | -56.81%-201.8K | -128.69K | 0 |
| Earnings from equity interest net of tax | ||||||||||
| Net income | 61.68%-802.96K | 0.57%-2.1M | -7.68%-2.11M | -34.01%-1.96M | -50.81%-1.46M | 69.56%-968.47K | -749.51%-3.18M | 90.84%-374.49K | -32.24%-4.09M | 56.08%-3.09M |
| Net income continuous operations | 61.68%-802.96K | 0.57%-2.1M | -7.68%-2.11M | -34.01%-1.96M | -50.81%-1.46M | 69.56%-968.47K | -749.51%-3.18M | 90.84%-374.49K | -32.24%-4.09M | 56.08%-3.09M |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | 61.68%-802.96K | 0.57%-2.1M | -7.68%-2.11M | -34.01%-1.96M | -50.81%-1.46M | 69.56%-968.47K | -749.51%-3.18M | 90.84%-374.49K | -32.24%-4.09M | 56.08%-3.09M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | 61.68%-802.96K | 0.57%-2.1M | -7.68%-2.11M | -34.01%-1.96M | -50.81%-1.46M | 69.56%-968.47K | -749.51%-3.18M | 90.84%-374.49K | -32.24%-4.09M | 56.08%-3.09M |
| Diluted earnings per share | 61.54%-0.0005 | 18.75%-0.0013 | 26.37%-0.0016 | 11.45%-0.0022 | -52.99%-0.0025 | 69.65%-0.0016 | -699.55%-0.0053 | 90.78%-0.0007 | -10.15%-0.0072 | 60.57%-0.0065 |
| Basic earnings per share | 61.54%-0.0005 | 18.75%-0.0013 | 26.37%-0.0016 | 11.45%-0.0022 | -52.99%-0.0025 | 69.65%-0.0016 | -699.55%-0.0053 | 90.78%-0.0007 | -10.15%-0.0072 | 60.57%-0.0065 |
| Dividend per share | ||||||||||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |